DRUG
Bright Minds Biosciences
DRUG
DRUG
14 hedge funds and large institutions have $509K invested in Bright Minds Biosciences in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.15% less ownership
Funds ownership: 0.82% → 0.67% (-0.15%)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14K | |
| 2 | +$14K | |
| 3 | +$13K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.17K |
Top Sellers
| 1 | -$86K | |
| 2 | -$9K | |
| 3 | -$6.67K | |
| 4 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$5.28K |